14504 results for "PLOS+ONE+Pennsylvania+German+ACS+language+code+pdc+open+access+study"

in 15.42 milliseconds.

• Inferring tumor genomes from peripheral blood i.e. CTCs and plasma-DNA using deep sequencing and targeted enrichment

  Study EGAS00001000337

• TallFlow: Lineage tracing of immunophenotypic sub populations in T-cell Acute lymphoblastic leukemia by (sc-)WGS

  Study EGAS00001007446

• Whole-genome sequencing of a census-based elderly cohort of Brazilians

  Study EGAS00001005052

• DNA polymerase and mismatch repair deficient cancers exert distinct genome-wide microsatellite signatures 2

  Study EGAS00001004816

• Small molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma (RNAseq dataset)

  Study EGAS00001004748

• Characterization of T cell tumor infiltration in brain metastases through the analysis of the cerebrospinal fluid

  Study EGAS00001004751

• CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas

  Study EGAS00001007577

• Single cell characterization of arrested B-lymphoid differentiation and leukemic cell states in ETV6-RUNX1-positive pediatric leukemia

  Study EGAS00001004374

• RNA sequencing of subchondral bone from patients that underwent a joint replacement surgery due to osteoarthritis.

  Study EGAS00001004476

• Colorectal cancer cells possess an equipotent capacity to enter a developmental pausing-like state to survive chemotherapy

  Study EGAS00001004773

• Clonal dynamics of normal hepatocyte expansions in homeostatic human livers and their association with the biliary epithelium

  Study EGAS00001005539

• Single-cell RNA sequencing of a PBMC sample collected from a male with 45,X/48,XYYY karyotype

  Study EGAS00001005697

• Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

  Study EGAS00001005791

• Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models

  Study EGAS00001006134

• Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial

  Study EGAS00001006342

• Complex patterns of genomic heterogeneity identified in 42 tumor samples and ctDNA of a pulmonary atypical carcinoid patient

  Study EGAS00001006530

• Targeted exome DNA sequencing analysis of POETIC Good/Poor Responders to aromatase inhibitors based on change in Ki67

  Study EGAS00001007303

• Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

  Study EGAS00001007430

• Therapeutic vulnerabilities in CCA from different etiologies identified using integrative multi-omics enhancer activity profiling

  Study EGAS00001007309

• RNA-seq of lung neuroendocrine tumors

  RNA-seq of lung neuroendocrine tumors

  Study EGAS50000000058

• A cycling, progenitor-like cell population at the root of atypical teratoid rhabdoid tumor subtype differentiation trajectories

  Study EGAS00001008123

• Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients

  Study EGAS00001005599

• Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

  Study EGAS00001004615

• Transcriptome Sequencing Data of High Grade Serous Ovarian Cancer

  Study EGAS00001004714

• Evolution_of_the_cancer_epigenome_in_myeloproliferative_neoplasms_2

  Whole genome sequencing and bisulphite sequencing of haematopoietic colonies

  Study EGAS00001002372